Uncategorised
Vaccine progress: HIV, TB, and more
This issue covers many recent advances in the vaccine field: the approval of the first Ebola vaccine, the exciting data on potential vaccine strategies against tuberculosis, and the start of a new HIV vaccine efficacy trial. But amidst all this progress, global cases of measles are on the rise, a disease for which a highly effective vaccine has been available for more than 50 years. Last year more than 140,000 people worldwide died of measles, most of them children under five years old, and 100 million cases of this vaccine-preventable disease were reported, according to the World Health Organization and the U.S. Centers for Disease Control and Prevention. As this grim statistic shows, the challenge is not only developing vaccines against existing and emerging pathogens, but also ensuring the public health impact of existing vaccines is fully realized.
READ MORE »
Special Features
Special Features
IAVI Report’s Special Features page offers a mix of video, audio, and printed materials that extend beyond what our regular bi-monthly publications offer. Here you will find audio chapters in our Living History of AIDS Vaccines series, which was launched in 2009. You can also find infographics, including an AIDS vaccine research timeline that is being updated periodically to reflect the ever-shifting tides of AIDS vaccine science, and special coverage of pivotal events like the RV144 trial that provided the first evidence of vaccine-induced protection against HIV.
Archives
Back Issues
IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. The publication features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.